Kyverna
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Learn more
Launch date
Employees
Market cap
$227m
Enterprise valuation
($110m) (Public information from Sep 2024)
Share price
$5.23 KYTX
Emeryville California (HQ)
Authorizing premium user...